Because less-invasive, nonsurgical approaches are needed to treat severe emphysema, authors of a new study compared the safety and efficacy of the Spiration Valve System with optimal medical management.
...
In addition to lowering the number of monthly migraine days, galcanezumab may also reduce the need for acute medication in patients with migraine. A new post-hoc analysis presented at the American Headache...
In a phase 2b/3 study, a new orally administered CGRP receptor antagonist showed positive results in preventing migraines. Results were presented at the American Headache Society’s 61st Annual Scientific...
Study results presented at the American Headache Society’s 61st Annual Scientific Sessions highlight a non-invasive alternative to opioids for the treatment of chronic migraine.
Dopamine is known to regulate striatal function and learning. In a new study, researchers applied this knowledge to determine whether post-stroke administration of dopaminergic therapy—in addition to...
In a new study, researchers aimed to better understand the effects of alcohol septal ablation for patients presenting with Fabry disease and left ventricular hypertrophy.
Researchers evaluated data from more than 200,000 new users of histamine H2 receptor antagonists or proton pump inhibitors to estimate all-cause mortality and cause-specific mortality associated with the...
Authors of a new study aimed to determine whether racial disparities in receiving pulmonary rehabilitation are explained by density of pulmonary rehabilitation programs and other community-level factors.
...
After 2 randomized clinical trials found it as safe and effective as the standard 3-drug regimen, the FDA approved the first 2-drug regimen for adults with HIV-1 who have never been treated with ART.
Guidelines from the American Academy of Neurology recommend stopping disease modifying therapy in those without relapsing MS and who are nonambulatory. Researchers of a study presented at ACTRIMS Forum 2019...
